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Cyclic AMP reverses radiocontrast media–induced apoptosis
in LLC-PK1 cells by activating A kinase/PI3 kinase
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Department of Hospital Pharmacy, Faculty of Medicine, Kyushu University, Higashi-ku, Fukuoka, Japan
Cyclic AMP reverses radiocontrast media–induced apoptosis in
LLC-PK1 cells by activating A kinase/PI3 kinase.
Background. Radiographic contrast material is one of agents
that are prone to cause nephropathy, although little is known
about cellular mechanisms underlying contrast media–induced
renal failure. The present study was designed to determine the
role of caspase in contrast media–induced renal injury. The mod-
ulation by cyclic adenosine monophosphate (cAMP) of cell in-
jury was subsequently examined.
Methods. LLC-PK1 cells (a proximal renal tubular cell line
of porcine origin) were exposed to diverse contrast media for
30 minutes followed by incubation for 24 hours in normal
medium. Cell viability was assessed by mitochondrial enzyme
activity and propidium iodide stain. Apoptosis was determined
by DNA electrophoresis and annexin V stain. Caspase activity
was measured fluorometrically. The mRNA for bax and bcl-2
was determined by reverse transcription-polymerase chain re-
action (RT-PCR).
Results. Iodinated and magnetic resonance contrast media re-
duced cell viability due to apoptosis. The cell damage induced
by a non-ionic contrast medium ioversol was inhibited by spe-
cific inhibitors for caspase-3 and -9 but not caspase-8. Ioversol
enhanced the activities of caspase-3 and -9, but to a lesser extent,
caspase-8. The bax mRNA was enhanced, while bcl-2 mRNA
was reduced, after exposure to ioversol. All of these actions of
ioversol were reversed by dibutyl cAMP in the manner sensitive
to a protein kinase A inhibitor H89 and a phosphatidylinositol
3 (PI3) kinase inhibitor wortmannin.
Conclusion. We demonstrated for the first time that cAMP
reversed caspase-dependent apoptotic renal cell damage caused
by contrast media. Both protein kinase A and PI3 kinase might
be involved in protective effect of cAMP.
Although the use of contrast media during radio-
graphic examinations is increasing in recent years,
nephropathy is a major complaint after intravascular
administration of radiographic contrast materials, partic-
ularly in patients with reduced renal function due to hy-
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pertension, diabetes mellitus, and cardiac failure [1–4].
Unfortunately, there has been few effective preventions
or cures for the contrast media nephropathy, except for
the massive fluid infusion. The etiology of renal failure
caused by contrast media remains to be clarified; how-
ever, the reduction in the renal blood flow as well as the
direct toxic action on renal tubular epithelial cells have
been postulated as the major causes of contrast media
nephropathy [5, 6]. It has recently been reported that ra-
diographic contrast agents induce apoptosis in glomeru-
lar cells and renal tubular epithelial cells [7–9]. Apoptosis
is characterized by cell shrinkage, chromatin conden-
sation, phosphatidylserine externalization, and nuclear
fragmentation [10]. The nuclear damage is considered to
be mediated by the activation of the cysteine protease
caspases [11, 12], although it is still uncertain whether
the contrast media stimulate the caspase activity to cause
nuclear damage.
Therefore, in the present study, we focused on the ef-
fect of radiographic contrast media on the viability of re-
nal tubular cells and investigated the effects of a variety
of radiographic contrast media, including ionic and non-
ionic iodinated contrast media and magnetic resonance
contrast materials, on the cell viability, nuclear arrange-
ment, and caspase activity in a porcine proximal tubular
cell line LLC-PK1 cells.
We have recently reported in cultured vascular en-
dothelial cells that a variety of radiographic contrast me-
dia reduce the cellular adenosine triphosphate (ATP)
content and induce cell injury characterized by the nu-
clear damage, in which a close correlation exists between
the extent of the decrease in ATP content and the loss
of cell viability [13]. The depletion of tissue ATP may
lead to the reduction in cyclic adenosine monophosphate
(cAMP) production. Indeed, we found that the cellular
cAMP content is severely depressed in rat peritoneal as
well as pulmonary mast cells after exposure to ionic con-
trast media [14]. Moreover, the degranulation of mast
cells induced by contrast materials is suppressed by a
membrane-permeable cAMP analogue such as dibutyl
cAMP (DBcAMP), or an activator of adenylate cyclase
forskolin [14].
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It has been demonstrated that cAMP signaling cascade
plays an important role in regulation of apoptotic injury
in a variety of cells [15–17]. Thus, the effect of the modu-
lation of cAMP signaling with DBcAMP on the contrast
media–induced injury in LLC-PK1 cells was subsequently
investigated.
METHODS
Materials
The iodinated radiographic contrast agents used in the
present study were amidotrizoate (Urographine, 292 mg
iodine/mL) (Schering AG, Berlin, Germany), ioxaglate
(Hexabrix 320, 320 mg iodine/mL) (Tanabe Seiyaku Co.,
Ltd., Osaka, Japan), sodium iotalamate (Conray 400,
400 mg iodine/mL) (Daiichi Pharmaceutical Co., Ltd.,
Tokyo, Japan), iohexol (Omnipaque 300, 300 mg io-
dine/mL) (Daiichi Pharmaceutical), iomeprol (Iomeron
400, 400 mg iodine/mL) (Eisai Co., Ltd., Tokyo), iopami-
dol (Iopamiron 300, 300 mg iodine/mL) (Schering
AG), ioversol (Optiray 350, 350 mg iodine/mL) (Ya-
manouchi Pharmaceutical Co., Ltd., Tokyo, Japan), and
iotorolan (Isovist 300, 300 mg iodine/mL) (Schering
AG) for iodinated contrast media. Meglumine gadopen-
tetate (Magnevist) (Schering AG) and gadoteridol
(Prohance) (Eisai Co., Ltd.) were used for magnetic
resonance contrast materials. Fluorescence-labeled cas-
pase substrates such as Ac-DEVD-AMC for caspase-3,
Ac-LEHD-AMC for caspase-9, and Ac-IETD-AMC for
caspase-8 were purchased from Alexis Biochemicals (San
Diego, CA, USA). Caspase inhibitors, including zVAD-
fmk (a nonspecific caspase inhibitor), zDEVD-fmk (a
caspase-3 specific inhibitor), zIETD–fmk (a caspase-8
specific inhibitor) and zLEHD–fmk (a caspase-9 spe-
cific inhibitor), and wortmannin, a PI3 kinase inhibitor,
were obtained from Calbiochem (San Diego, CA, USA).
DBcAMP, D-mannitol, and 3-isobutyl-1-methylxanthine
(IBMX) were obtained from Sigma Chemical Co. (St.
Louis, MO, USA). H89, a protein kinase A (PKA) in-
hibitor was purchased from Seikagaku Co., Ltd. (Tokyo,
Japan). The osmolality of iodinated contrast media so-
lution (25 to 150 mg iodine/mL) was measured by the
freezing point depression technique using calibrated os-
mometer (Om 801) (Asahi Life Science, Tokyo, Japan).
Cell culture
LLC-PK1 cells (a proximal renal tubular cell line of
porcine origin) were obtained from the American Type
Culture Collection (Rockville, MD, USA). Cells were
grown in 75 cm2 flask (Corning Incorporated, Corning,
NY, USA) and maintained in Medium 199 (ICN Biomed-
icals, Inc., Aurora, OH, USA) supplemented with 10%
fetal bovine serum (FBS) (JRH Bioscience, Inc., Lenexa,
KS, USA) 60 lg/mL penicillin (Sigma Chemical Co.) in an
atmosphere of 5% CO2 in air at 37◦C. For experiment,
cells were seeded on 24-well plates (Falcon) (Becton
Dickinson Co., Ltd., Franklin Lakes, NJ, USA) at a den-
sity of 1.0 × 104 cells/cm2 and cultured at 37◦C for
24 hours.
Cell viability
Cells were exposed to iodinated radiographic con-
trast media (25 to 150 mg iodine/mL for ioversol
and 150 mg iodine/mL for other contrast materials)
or magnetic resonance contrast media (twofold dilu-
tion) for 30 minutes at 37◦C, then the medium was
washed twice with Krebs-Ringer solution, and incu-
bated in serum-free culture medium for 24 hours
at 37◦C in 5% CO2/95% air. The cell viability was
assessed by the mitochondrial activity in reducing
WST-8 [2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-
5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt]
to formazan [18]. Cells were incubated at 37◦C for
90 minutes in 210 lL of serum-free medium containing
10 lL of WST-8 assay solution (Cell Counting Kit-8, Do-
jindo Laboratory, Kumamoto, Japan). Aliquots of the
incubation medium was transferred to a 96-well mi-
croplates (Corning Incorporated) and absorbance was
measured at 620 nm with the reference wavelength
of 450 nm using a microplate reader (Immuno Mini
NJ-2300) (Inter Med, Tokyo, Japan).
To determine the role of caspases in contrast
media–induced cell death, caspase inhibitors, including
zVAD-fmk for pan caspase (30 lmol/L), zDEVD-fmk
for caspase-3 (50 lmol/L), zIETD-fmk for caspase-8
(50 lmol/L), and zLEHD-fmk for caspase-9 (50 lmol/L),
were added 1 hour before contrast media treatment and
included throughout the experiment. To demonstrate
roles of PKA and phosphatidylinositol 3 (PI3) kinase in
the action of DBcAMP, a PKA inhibitor H89 (30 lmol/L)
or a PI3 kinase inhibitor wortmannin (10 nmol/L) was
added 11/2 hours before, while DBcAMP (1 mmol/L)
was included 1 hour before, the treatment with contrast
media.
Annexin V and propidium iodide stains
Annexin V and propidium iodide stains were per-
formed by using Mebcyto Apoptosis Kit (Medical & Bi-
ological Laboratories Co., Ltd., Nagoya, Japan). LLC-
PK1 cells were cultured for 24 hours on 8-chamber plastic
slides (Iwaki, Asahi Techno Glass Co., Tokyo, Japan) at
a density of 1.0 × 104 cells/chamber. Cells were washed
twice with phosphate-buffered saline (PBS), and incu-
bated for 30 minutes in the dark in 100 lL buffer con-
taining 10 lL fluorescent isothiocyanate (FITC)-labeled
annexin V or 2 lL propidium iodide. Cells were washed
twice with buffer and visualized using a fluorescent mi-
croscopy (BX51) (Olympus, Tokyo, Japan) under ×100
magnification.
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DNA electrophoresis
The internucleosomal DNA fragmentation was as-
sessed by agarose gel electrophoresis. DNA was isolated
using DNA extractor WB kit (Wako Pure Chemicals, Os-
aka, Japan). Briefly, LLC-PK1 cells were trypsinized and
centrifuged at 150g for 10 minutes. The resultant pellets
were dissolved in 1 mL of lysis solution and centrifuged
again at 10,000g for 20 minutes at 4◦C, then the pellets
were resuspended in 200 lL of enzyme reaction solution.
To the suspension, 10 lL protease solution was added
and incubated at 37◦C for 1 hour, then sodium iodide
was included. DNA was extracted with isopropanol. The
isolated DNA was then treated with 10 lg RNase A (ICN
Biomedicals, Inc.) at 37◦C for 30 minutes, and subjected to
electrophoresis with 2% agarose gel. After electrophore-
sis, DNA was visualized after staining with ethidium
bromide.
Assay for caspase activity
Caspase activities were determined fluorometrically
by the degradation of the peptide substrates specific for
caspase-3 (DEVD-AMC), caspase-8 (IETD-AMC), or
caspase-9 (LEHD-AMC), based on the protocols for
the caspase activity assay kit (BioVision, Inc., Moun-
tain View, CA, USA). The contrast media–treated cells
were centrifuged at 150g for 10 minutes, and the resul-
tant pellets were suspended in 1 mL lysis buffer (Bio-
Vision, Inc.) and subjected to caspase activity assay.
The reaction was started by incubating the enzyme ex-
tracts with each caspase substrate for 10 minutes in
the absence or presence of caspase inhibitors, includ-
ing zDEVD-fmk for caspase-3, zIETD-fmk for caspase-
8, and zLEHD-fmk for caspase-9. After centrifugation
at 10,000g for 10 minutes, the concentration of AMC
(7-amino-4-methylcoumarin) in the supernatant was de-
termined at an excitation wavelength of 380 nm and an
emission wavelength of 460 nm using a fluorescent spec-
trofluorometer (Corona Co., Ltd., Niigata, Japan). The
protein concentration was measured according to the
method of Bradford [19]. The caspase activity was ex-
pressed as nmol of AMC produced per mg protein.
Reverse transcription-polymerase chain
reaction (RT-PCR)
The mRNA was isolated from LLC-PK1 cells using a
Quick preparation micro mRNA purification kit (Amer-
sham Biosciences Limited, Buckinghamshire, UK).
Briefly, cells were homogenized with 0.6 mL extraction
buffer, then 0.8 mL elution buffer was added to the
extract and mixed thoroughly by Vortex mixer. After
centrifugation at 10,000g for 1 minute, the supernatant
was applied to the oligo (dT)-cellulose, and washed
with a high-salt buffer, then with a low-salt buffer, and
transferred to a sterile microcentrifuge tube. Then, the
mRNA was eluted with the elution buffer and quantified
by measuring the absorbance at 260 nm. The mRNA
solution was diluted with 20 lL RNase-free water and
cDNA was synthesized by using a first-strand cDNA
synthesis kit (Amersham Biosciences Limited). The PCR
was carried out in 25 lL of samples containing cDNA
(corresponding to 50 ng of mRNA), 10 pmol/lL of each
oligonucleotide primer, 2.5 mmol/L of desoxynucleoside
triphosphate (dNTP) and 5 U/lL of Taq polymerase
(Nippon Gene, Co., Ltd., Tokyo, Japan). Amplification
was carried out for 30 cycles (denaturation at 94◦C for
30 seconds, annealing at 60◦C for 30 seconds, and
elongation at 72◦C for 30 seconds), followed by an
additional polymerization at 72◦C for 5 minutes, using a
Program Temp Control System PC-707 (Astec, Co., Ltd.,
Fukuoka, Japan). The oligonucleotide primers for bcl-2,
bax and b-actin were designed based on the sequences
described by Rey C et al [20] and Kim et al [21], respec-
tively. The sequences of PCR primers were as follows:
5′-AGCGTCAACGGGAGATGTC-3′ (sense) and 5′-
GTGATGCAAGCTCCCACCAG-3′ (antisense) for
bcl-2; 5′-CAGCTCTGAGCAGATCATGAAGACA-3′
(sense) and 5′-GCCCATCTTCTTCCAGATGGTGA
GC-3′ (antisense) for bax; and 5′-TGAGACCTTCA
ACACGCCG-3′ (sense) and 5′-ATGGTGATGACC
TGCCCGTC-3′ (antisense) for b-actin. The primers
were purchased from Sigma Genosys Japan Co., Ltd.
(Sapporo, Japan). The PCR products were subjected
to electrophoresis on 2% agarose gel and the DNA
was visualized by staining with ethidium bromide under
ultraviolet irradiation. Then, the intensities of PCR
products were semiquantified densitometrically using
Alpha Imager 2200 (Alpha Innotech Corporation, San
Leandro, CA, USA). The mRNA for b-actin was used
as the standard.
Statistical analyses
Data are expressed as the mean ± SEM and statistically
analyzed by one-way analysis of variance followed by the
Dunnett test for multiple comparisons, or by the Student
t test for comparison between two groups (Stat View;
Abacus Concepts, CA, USA). Statistical significance was
defined as P < 0.05.
RESULTS
Effects of a variety of radiographic contrast media
on the viability of LLC-PK1 cells
The effects of ionic and nonionic iodinated radio-
graphic contrast media and magnetic resonance contrast
materials on the viability of LLC-PK1 cells were com-
pared. As shown in Figure 1A, most of the contrast
media tested reduced the viability determined by the
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Fig. 1. Decrease in the viability of a porcine proximal cell line LLC-PK1 cells by various iodinated and magnetic resonance contrast media (A) and
the lack of correlation between the reduction of cell viability and the osmolality of iodinated contrast media (B). Cells were exposed for 30 minutes at
37◦C to eight different iodinated contrast media (each 150 mg iodine/mL), including ioxaglate (IOX), sodium iotalamate (IOT), and amidotrizoate
(AMD) for ionic agents and iohexol (IHX), iopamidol (IPD), ioversol (IVS), iomeprol (IMP), and iotrolan (ITL) for nonionic contrast media, and
two different magnetic resonance contrast media (each ×2 dilution) such as gadopentetate (GPT) and gadoteridol (GTD) in serum-free medium,
followed by further incubation for 24 hours at 37◦C in the absence of contrast media. Cell viability was assessed by the mitochondrial dehydrogenase
activity using WST-8. In (B), the osmolality of 150 mg iodine/mL of each iodinated contrast media solution was measured by the freezing point
depression method using a calibrated osmometer. Data show the means ± SEM (N = 6 ∼ 8). ∗P < 0.05:; ∗∗P < 0.01 vs. control (Dunnett test)
mitochondrial dehydrogenase activity to reduce WST-8,
when the cells were exposed to 150 mg iodine/mL of con-
trast media for 30 minutes followed by further incuba-
tion for 24 hours in the absence of these materials. The
ionic contrast media such as amidotrizoate, ioxaglate, and
sodium iotalamate all significantly reduced the viability.
Among nonionic iodinated contrast materials, ioversol
was most marked in producing the cell injury, while io-
hexol and iomeprol caused a slight and not significant
reduction in cell viability. On the other hand, both the
magnetic resonance contrast media gadopentetate and
gadoteridol significantly decreased the cell viability. It
was unlikely that the toxic actions of these contrast media
were associated with the hyperosmolality of these agents
since there was no correlation (r = −0.652, P = 0.08)
between the decrease in cell viability and the osmolal-
ity determined by the freezing point depression analysis
(Fig. 1B).
Since ioversol, a popularly used nonionic contrast ma-
terial, caused a marked cell damage in LLC-PK1 cells,
the toxic effect of this material was investigated in the
subsequent study.
Concentration- and time-dependent injury in LLC-PK1
cells after a transient exposure to ioversol
As shown in Figure 2A, ioversol (25 to 150 mg io-
dine/mL) produced a concentration-dependent decrease
in cell viability as assessed by WST-8 method, when tested
at 24 hours after a transient exposure of LLC-PK1 cells
to ioversol. The significant action was observed even at
the concentration 25 mg iodine/mL. The concentration-
dependent cell injury induced by ioversol was also ob-
served when the osmolality of the solution was adjusted
constant (530 mOsm/kg). The toxic effect of ioversol was
time-dependent, in which the significant injury was ob-
served already at 1 hour after the removal of ioversol
(Fig. 2B).
Role of caspases in the ioversol-induced cell injury
The ioversol-induced cell damage was evaluated by
staining with propidium iodide and annexin V. As shown
in Figure 3, the number of cells positively stained with
propidium iodide and annexin V markedly increased at
24 hours after a transient exposure of LLC-PK1 cells
to 100 mg iodine/mL ioversol. The ioversol-induced in-
creases in propidium iodide– and annexin V–positive
cells were reversed by zVAD-fmk, a pan caspase inhibitor
[22]. Then, we determined which types of caspases were
involved in the ioversol-induced cell damage. The in-
crease in propidium iodide– and annexin V–stained cells
induced by ioversol were inhibited by zDEVD-fmk, a
caspase-3 inhibitor [23], and zLEHD-fmk, a caspase-9 in-
hibitor [24], but not by zIETD-fmk, a caspase-8 inhibitor
[23].
As shown in Figure 4A, a typical DNA ladder deter-
mined by agarose gel electrophoresis was observed in
ioversol-treated cells. As observed in propidium iodide
and annexin V stains, the ioversol-induced DNA frag-
mentation was suppressed by zDEVD-fmk and zLEHD-
fmk but not by zIETD-fmk.
Caspase activation after exposure of LLC-PK1
cells to ioversol
To confirm that ioversol stimulates caspase activity,
the activities of the caspases including caspase-3, -8,
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Fig. 3. Involvement of caspase-3 and caspase-9 but not caspase-8 in the ioversol-induced injury in LLC-PK1 cells as assessed by annexin V and
propidium iodide (PI) stains (×100 magnification). (A) Cells not treated. (B) Cells were exposed to ioversol (100 mg iodine/mL) for 30 minutes
at 37◦C, followed by further incubation for 24 hours at 37◦C in the absence of ioversol. Caspase inhibitors, including (C) zVAD-fmk (pan caspase
inhibitor, 30 lmol/L), (D) zDEVD-fmk (caspase 3 inhibitor, 50 lmol/L), (E) zIETD-fmk (caspase 8 inhibitor, 50 lmol/L), and (F) zLEHD-fmk
(caspase 9 inhibitor, 50 lmol/L), were added 1 hour before ioversol treatment and included throughout the experiment. Cells were visualized using
a fluorescent microscopy under ×100 magnification.
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and -9 were measured after exposure of LLC-PK1 cells
to ioversol by the degradation of subtype-specific pep-
tide substrates labeled with the fluorescent AMC. As
shown in Figure 4B, ioversol caused a marked increase in
caspase-3 and -9 activities, when determined at 24 hours
subsequent to a transient exposure to this contrast
medium for 30 minutes. Moreover, ioversol produced
a slight but not significant enhancement of caspase-8
activity.
Effect of ioversol on mRNA expression for bcl-2 and bax
in LLC-PK1 cells
The activities of caspases, particularly caspase-3 and -9,
are known to be regulated negatively by the antiapoptotic
protein Bcl-2 and positively by the proapoptotic protein
Bax, and the ratio of Bax to Bcl-2 is considered to be
one of determinants of caspase activation. As shown in
Figure 5, ioversol induced a decrease in the expression for
bcl-2 mRNA and a concomitant increase in bax mRNA
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expression. Thus, the ratio of the mRNA expression for
bax to bcl-2 increased to 3.4-fold as that observed in con-
trol cells.
Protective effect of DBcAMP against ioversol-induced
injury in LLC-PK1 cells
To investigate the effect of cAMP on the renal dam-
age induced by contrast media, the effect of DBcAMP, a
membrane-permeable cAMP analogue [25], on ioversol-
induced injury in LLC-PK1 cells was examined. As shown
in Figure 6, the ioversol-induced cell injury was reversed
by DBcAMP in a concentration-dependent manner. The
protective effect of DBcAMP was also confirmed by the
facts that the ioversol-induced increases in the number
of propidium iodide– and annexin V–positive cells were
reversed by 1 mmol/L DBcAMP (Fig. 7). In addition,
DBcAMP (1 mmol/L) completely blocked the DNA lad-
der induced by ioversol (Fig. 8, lane 3). The inhibitory
effect of DBcAMP on ioversol-induced DNA fragmen-
tation was reversed by 30 lmol/L H89, a specific PKA
inhibitor [26], or 10 nmol/L wortmannin, a PI3 kinase in-
hibitor [27], although either H89 or wortmannin alone
caused only a slight DNA fragmentation.
Effect of DBcAMP on ioversol-induced bcl-2 and bax
mRNA expression in LLC-PK1 cells
As shown in Figure 9A, the decrease in bcl-2 mRNA in-
duced by ioversol was completely blocked by 1 mmol/L
DBcAMP, while this nucleotide partially inhibited the
ioversol-induced enhancement of bax mRNA expres-
sion (Fig. 9B). As a result, the ioversol-induced increase
in the ratio of bax mRNA/bcl-2 mRNA was greatly
depressed by DBcAMP (Fig. 9C). As observed in the
data on DNA fragmentation, the inhibitory effect of
DBcAMP on ioversol-induced changes in mRNA expres-
sion for bcl-2 and bax was almost completely reversed by
30 lmol/L H89 or 10 nmol/L wortmannin.
DISCUSSION
Contrast media nephropathy is a serious problem, par-
ticularly when the radiographic examinations are made
in patients with renal dysfunction. Several mechanisms,
including the decrease in renal blood flow and the di-
rect toxic action on renal tubular cells, have been pos-
tulated as the cause of the nephrotoxicity of contrast
media, although the precise modes of action of contrast
media–induced nephrotoxicity remain to be clarified. In
the present study, we focused on the direct toxic action
of radiographic contrast media in cultured renal tubular
cell line LLC-PK1 cells. Since radiographic contrast me-
dia are known to reduce cellular cAMP in mast cells [14],
while cellular cAMP signaling has an important role in the
survival of a variety of cells, we investigated the cellular
mechanisms underlying the injury of renal tubular cells
induced by contrast media, particularly in relation to the
cAMP signaling. We found for the first time that radio-
graphic contrast media caused an apoptosis in LLC-PK1
cells through the mechanism dependent on the activity
of caspase-9 and caspase-3. Moreover, the enhancement
of cellular cAMP signaling with DBcAMP was found to
protect LLC-PK1 cells against contrast media–induced
apoptosis through PKA/PI3 kinase–dependent mecha-
nisms. Therefore, any agents that increase the cellular
cAMP level or activates PI3 kinase may become a useful
tool for the prophylaxis of contrast media nephropathy.
In the present study, a number of iodinated as well as
magnetic resonance contrast media reduced more or less
the viability of LLC-PK1 cells determined by WST-8 as-
say, when they were treated transiently for 30 minutes.
WST-8 assay is a reproducible and sensitive method for
assessing cell viability, since the amount of water-soluble
formazan produced by mitochondrial nicotinamide ade-
nine dinucleotide (NADH) enzymes is proportional to
the number of viable cells [18]. The toxic effect of con-
trast media was also confirmed by the fact that ioversol
increased the number of cells stained with propidium io-
dide, which can enter the damaged cells through perme-
abilized plasma membranes and bind to nuclei [28].
The concentrations of a variety of contrast materials
used in the present study seemed to be high (100 to 150 mg
iodine/mL). In clinical setting, the injection volume of
radiographic contrast media is usually 25 to 50 mL (7.5 to
20 g iodine), resulting in plasma concentrations of 1.5 to
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A Non-treatment
B Ioversol (100 mg iodine/mL for 30 minutes) at 24 hours
C Ioversol + DBcAMP (1mmol/L)
Annexin V
PI
Fig. 7. Protective effect of dibutyl cyclic
adenosine monophosphate (DBcAMP)
against ioversol-induced injury in LLC-PK1
cells as determined by annexin V and
propidium iodide (PI) stains. (A) Cells not
treated. (B) Cells were exposed to ioversol
(100 mg iodine/mL) for 30 minutes at 37◦C,
followed by further incubation for 24 hours
at 37◦C in the absence of ioversol. (C)
DBcAMP (1 mmol/L) were added 1 hour
before ioversol treatment and included
throughout the experiment. Cells were
visualized using a fluorescent microscopy
under ×100 magnification.
2.0 mg iodine/mL. However, the intravascularly injected
contrast media are concentrated in the renal proximal
tubules, thereby leading to much higher concentrations
in the tubular cells than in plasma [29]. According to the
report by Spataro, Fischer, and Boylan [30], the urinary
concentrations of ioxaglate in rabbits is maximal (145 mg
iodine/mL) at 1 hour after injection of 450 mg iodine/kg, a
dose that is comparable to the clinical dose. Therefore, it
is assumed that the concentrations of contrast materials
used in the present study are within the range of their
renal concentrations that are expected in the clinical use.
On the other hand, the concentration-response study for
ioversol showed that as low as 25 mg iodine/mL of this
contrast medium significantly decreased the cell viability.
It has been reported that ionic iodinated contrast me-
dia are more potent in producing renal dysfunction than
nonionic agents, in which the incidence of renal failure
is 27% (30 out of 111 patients) for an ionic agent dia-
trizoate and 12% (12 out of 102 patients) for a nonionic
material iohexol [2], although other investigators have
reported no difference in the incidence of nephrotoxicity
between ionic and nonionic contrast agents [31]. Con-
sistent with the latter case, our present data showed that
there was no marked difference in the extent of cell injury
among various types of contrast media, including ionic-
and nonionic-iodinated and magnetic resonance radio-
graphic contrast materials. The lack of influence of renal
flow in the present study may cause such an inconsistency.
Although the mechanisms underlying the direct toxic
actions of contrast media on renal tubular cells are not
fully understood, hyperosmolality of the contrast media
solution is considered to be associated with the cell dam-
age [8, 32]. However, the contribution of osmolality to
the contrast media–induced nephropathy is still a matter
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M 1 2 3 4 5 6 7
Fig. 8. Involvement of protein kinase A (PKA) and phosphatidylinosi-
tol 3 (PI3) kinase in the reversal by dibutyl cyclic adenosine monophos-
phate (DBcAMP) of ioversol-induced DNA fragmentation in LLC-
PK1 cells. Cells were exposed to ioversol (100 mg iodine/mL) for
30 minutes at 37◦C, followed by further incubation for 24 hours at 37◦C
in the absence of ioversol. H89 (30 lmol/L) or wortmannin (10 nmol/L)
was added 11/2 hours before, while DBcAMP (1 mmol/L) was included
1 hour before ioversol treatment. DNA was isolated and subjected to
agarose gel electrophoresis. Lane M, DNA molecular weight marker
VIII; lane 1, nontreatment; lane 2, ioversol (100 mg iodine/mL); lane
3, ioversol + DBcAMP (1 mmol/L); lane 4, ioversol + DBcAMP
(1 mmol/L) + H89 (30 lmol/L); lane 5, ioversol + DBcAMP (1 mmol/L)
+ wortmannin (10 nmol/L); lane 6, H89 (30 lmol/L); and lane 7, wort-
mannin (10 nmol/L).
of controversy [33, 34]. In the present study, there was no
significant relationship between the osmolality and the
extent of cell damage, thereby suggesting the lack of sig-
nificant role for hyperosmolality in the renal tubular cell
injury induced by contrast materials.
It has recently been shown that radiographic contrast
agents cause an apoptosis in glomerular and renal tubu-
lar epithelial cells [7–9]. Consistent with their data, the
cell injury caused by a number of radiographic contrast
media observed in the present study seemed to be apop-
tosis based on the following findings: First, a number of
annexin V–stained cells were observed, when LLC-PK1
cells were exposed to ioversol for 30 minutes followed
by incubation for a further 24 hours in the absence of
the contrast medium. Annexin V binds preferentially to
phospholipids species such as phosphatidylserine, which
are normally absent on the surface of plasma membranes
but translocated to the outer layer of membranes during
the initial stage of apoptosis [35]. Second, ioversol caused
a nuclear fragmentation as assessed by agarose gel elec-
trophoresis of DNA.
To our knowledge, this is the first report showing the
involvement of caspases in the renal tubular cell injury
caused by radiographic contrast media. In our present
study, the cell damage (propidium iodide stain) as well as
the DNA fragmentation caused by ioversol were both re-
versed by a pan caspase inhibitor zVAD-fmk, caspase-3–
specific inhibitor zDEVD-fmk and a caspase-9 inhibitor
zLEHD-fmk but not by a caspase-8–specific inhibitor
zIETD-fmk, thereby suggesting that the ioversol-induced
apoptotic renal tubular injury is mediated by the acti-
vation of caspases-3 and -9 but not caspase-8. Consis-
tent with these findings, a marked enhancement of the
activities of caspases-3 and -9 was observed after ex-
posure of LLC-PK1 cells to ioversol, although ioversol
caused a slight but significant increase in caspase-8 ac-
tivity. It has been demonstrated that the enhancement
of caspase-9 activity triggers the activation of caspase-
3, leading to the chromosomal DNA fragmentation and
cellular morphologic changes characteristic of apopto-
sis [11, 12]. Caspases are generally classified into initia-
tors and executioners of apoptosis, in which the initia-
tors such as caspases-8 and -9 stimulate the activity of
the executioners including caspase-3 to cause apopto-
sis [11, 12]. Therefore, it is suggested that the contrast
media–induced apoptosis is mediated by the activation
of caspase-3 subsequent to the enhancement of caspase-9
activity.
On the other hand, the activity of caspase-9 is regulated
by bcl-2 family including Bcl-2 and Bax [36–38]. In addi-
tion, the ratio of Bax to Bcl-2 is considered to be an im-
portant determinant of caspase activation and induction
of apoptosis [36–38]. In the present study, the expression
for bcl-2 mRNA was reduced, while that for bax mRNA
was enhanced by ioversol, resulting in a marked elevation
of the ratio for bax mRNA to bcl-2 mRNA. Therefore,
our data suggest that contrast media may cause apop-
tosis of renal tubular cells by enhancing bax expression
and reducing bcl-2 expression, which in turn, stimulates
caspase-9 followed by caspase-3 activation and leads to
nuclear fragmentation.
We report here for the first time that a membrane-
permeable cAMP analogue DBcAMP inhibited the
contrast medium–induced cell injury by reversing the
changes in the expression for bax/bcl-2 mRNA. In our
previous report where the modulatory effect of cAMP on
radiographic contrast media–induced histamine release
from rat peritoneal and pulmonary mast cells was exam-
ined, an ionic contrast medium ioxaglate causes a marked
increase in histamine release with a concomitant reduc-
tion in the cellular cAMP content [14]. Moreover, the
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Fig. 9. Involvement of protein kinase A (PKA) and phosphatidylinositol 3 (PI3) kinase in the reversal by dibutyl cyclic adenosine monophosphate
(DBcAMP) of ioversol-induced changes in the mRNA expression for bcl-2 (A), bax (B) and the ratio of bax mRNA/bcl-2 mRNA (C) in LLC-PK1
cells. Cells were exposed to ioversol (100 mg iodine/mL) for 30 minutes at 37◦C, followed by further incubation for 24 hours at 37◦C in the absence
of ioversol. H89 (30 lmol/L) or wortmannin (10 nmol/L) was added 11/2 hours before, while DBcAMP (1 mmol/L) was added, and 1 hour before
ioversol treatment. The mRNA was isolated and mRNAs for bcl-2 and bax were measured by reverse transcription-polymerase chain reaction
(RT-PCR). The intensities of PCR products were determined by densitometric analysis. Histograms show the relative concentration of mRNAs for
bcl-2 (A) and bax (B) to b-actin mRNA. Data represent the ± SEM of four to six experiments. ∗∗P < 0.01 vs. ioversol + DBcAMP (Dunnett test).
ioxaglate-induced mast cell histamine release is greatly
reduced by DBcAMP, thereby indicating that the reduc-
tion in cellular cAMP signaling contributes at least in part
to the mast cell degranulation induced by contrast me-
dia [14]. However, in the present study, ioversol did not
change the cellular cAMP content in LLC-PK1 cells. The
values were 3.5 ± 0.4 pmol/mg protein (mean ± SEM,
N = 3) for nontreated cells, 14.2 ± 0.7 (N = 6) for IBMX-
treated control cells, 14.3 ± 0.7 (N = 6) for IBMX +
ioversol 25 mg iodine/mL, 14.9 ± 0.7 (N = 6) for IBMX
+ ioversol 50 mg iodine/mL, and 14.8 ± 0.5 (N = 6) for
IBMX + ioversol 100 mg iodine/mL. Therefore, it is un-
likely that the decrease in cellular cAMP contributes di-
rectly to the induction of apoptotic injury in LLC-PK1
cells induced by ioversol.
It has been reported that cAMP plays an important
role in the regulation of apoptotic injury in a variety of
cells including human breast cancer cell line MCF-7, rat
sympathetic neurons and human neutrophils [15–17]. In
addition, it is noteworthy that the protective effect of
cAMP was reversed by a PKA inhibitor H89 and a PI3
kinase inhibitor wortmannin. Particularly, the inhibitory
effect of cAMP on ioversol-induced DNA fragmentation
and reduction in bcl-2 mRNA were almost completely re-
versed by H89 and wortmannin, thereby suggesting that
antiapoptotic action of cAMP is mediated by the activa-
tion of PKA and PI3 kinase.
It has been shown that cAMP is involved in a number
of physiologic functions via activation of several signaling
pathways, including PKA, phosphodiesterases, cAMP re-
sponsive element binding protein (CREB), and cAMP-
regulated guanine nucleotide exchange factors [39, 40].
Moreover, cAMP can activate PI3 kinase in various types
of cells, including ovarian granulosa cells, cultured rat
hepatocytes, and a monkey kidney cell COS-7 [41, 42].
We do not know at present how PKA stimulates PI3 ki-
nase. Kagawa et al [43] have reported in COS-7 that Ras is
required for cAMP-induced activation of PI3 kinase. The
guanosine triphosphate (GTP)-bound Ras is reported to
be associated with the catalytic subunit of PI3 kinase to
enhance the catalytic activity [44]. Moreover, cAMP stim-
ulates the extracellular signal-regulated kinases (ERK), a
downstream target of PI3 kinase/Akt, by activating Ras in
melanocytes [45]. In addition, the cAMP-induced activa-
tion of PI3 kinase in COS-7 is abolished by the expression
of dominant-negative Ras, suggesting an involvement of
Ras in cAMP-induced activation of PI3 kinase [43].
It has been demonstrated that PKA promotes the ex-
pression of bcl-2 by phosphorylating CREB and facil-
itating the binding of this transcription factor to the
promoter region (CRE) of bcl-2 gene [46, 47]. On the
other hand, the activation of PI3 kinase is reported to in-
hibit apoptosis in rat pheochromocytoma cells, fibroblast
rat-1 cells, and rat hepatocytes through phosphorylation
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of Bad subsequent to the activation of Akt/PKB [48, 49].
Bad, which is associated with Bcl-2 to inhibit the action
of this antiapoptotic protein, is inactivated after phos-
phorylation. In the present study, the inhibitory effect of
cAMP on the ioversol-induced decrease in the expression
for bcl-2 mRNA was completely reversed by wortman-
nin, thereby suggesting that the PKA-dependent action
on bcl-2 mRNA is mediated entirely by activation of PI3
kinase/Akt pathway, although we did not measure the
changes in Bax or Bcl-2 proteins.
On the other hand, ioversol did not reduce the cAMP
concentration in LLC-PK1 cells. In addition, treatment
of cells with H89 or wortmannin alone did not cause
a marked DNA fragmentation in LLC-PK1 cells in the
present study. Therefore, it is unlikely that the reduction
in the activity of PKA or PI3 kinase is associated directly
with the etiology of the contrast media–induced injury of
renal tubular cells.
Further studies are needed to clarify the mechanisms
underlying the contrast media–induced increase in bax
mRNA/bcl-2 mRNA ratio and caspase activation. More-
over, the role of endogenous cAMP in contrast media–
induced apoptosis should also be elucidated.
CONCLUSION
A variety of radiographic contrast media caused apop-
tosis in LLC-PK1 cells by enhancing the activities of
caspase-9 and caspase-3 subsequent to the increase in
mRNA expression for bax and reduction in bcl-2 mRNA.
The cell injury was not dependent on the osmolality of
the solution. DBcAMP suppressed the contrast media–
induced apoptosis, an action that was dependent on
the activities of both PKA and PI3 kinase. Moreover,
DBcAMP reversed the contrast media–induced increase
in the ratio of bax mRNA/bcl-2 mRNA and caspase ac-
tivation in a manner dependent on the activities of PKA
and PI3 kinase. Therefore, our present findings suggest
that agents that stimulate the cellular cAMP production
become a useful tool for the prophylaxis of apoptotic re-
nal tubular cell injury induced by radiographic contrast
media.
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